CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$56.22 USD
+0.55 (0.99%)
Updated May 17, 2024 04:00 PM ET
After-Market: $55.90 -0.32 (-0.57%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.50 | 4.48% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$1.43 per share, beating the Zacks Consensus Estimate of $-1.63 per share. This reflects a positive earnings surprise of 12.27%. Look out for CRSP's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.50 per share, reflecting a year-over-year decrease of 53.06%.
Earnings History
Price & Consensus
Zacks News for CRSP
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services